Up until now, the standard treatment for myopia was to prescribe ... This could be an effective strategy in slowing myopia progression in children, Berntsen said. Especially as the problem appears ...

Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, ...

Following the switch from multifocal to single-vision contact lenses, axial elongation increased by 0.03 mm/year, and myopia ...

"The laser beam can be positioned with great accuracy on surfaces, so we can produce significantly smaller microlenses than is possible with previously existing methods," commented Thomas Höche head ...

“Recognizing a 2-year delay in treatment initiation in the group of children originally assigned to placebo, 0.05% atropine eyedrops slowed both myopia progression and axial eye growth over the ...

Source Reference: Loughman J, et al "Efficacy and safety of different atropine regimens for the treatment of myopia in children: three-year results of the MOSAIC randomized clinical trial" JAMA ...

Children who wore soft multifocal contact lenses for myopia control had no loss of treatment effect after discontinuing the ...

The study found that children who instilled nightly 0.05% atropine eye drops experienced less myopia progression than those receiving placebo drops ...

With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...